Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Poultry pharmaceuticals comprise vaccines, feed additive medication, and drugs such as parasiticides, and specialized products used to manage reproductive, metabolic or infectious diseases.

The global poultry pharmaceuticals market is estimated to account for US$ 5,807.2 Mn in terms of value and is expected to reach US$ 10,095.6 Mn by the end of 2027.

Global Poultry Pharmaceuticals Market: Drivers

Increasing consumption of chicken is expected to propel growth of the global poultry pharmaceuticals market over the forecast period. For instance, according to research presented at the 2018 Chicken Marketing Summit, Florida, U.S., 86% of consumers during a two week survey in the U.S. ate a chicken meal or snack purchased from a supermarket and 68% ate a chicken meal or snack from a food service establishment.

Moreover, significant growth of the poultry sector is also expected to aid in growth of the market. For instance, according to a report in 2019, by the U.S. Poultry and Egg Association, National Chicken Council, National Turkey Federation and United Egg Producers, the poultry sector generated US$ 495.1 billion in economic activity and US$ 38.5 billion in government revenue.

Vaccines held dominant position in the global poultry pharmaceuticals market in 2019, accounting for 40.7% share in terms of value, followed by feed additive and drugs, respectively.

Figure 1. Global Poultry Pharmaceuticals Market Share (%), by Value, by Product Type, 2019

Poultry Pharmaceuticals  | Coherent Market Insights

Global Poultry Pharmaceuticals Market: Restraints

Low product exclusivity, generic competition, and stringent regulations are expected to hinder growth of the global poultry pharmaceuticals market. Product exclusivity period is only three to five years in the animal health care industry. Shorter exclusivity period results in increased competition from generics and over-the-counter (OTC) products. Additionally, stringent regulations for product approval and limited vaccine production hampers growth of the market.

Moreover, increasing concerns about the use of antibiotics and growth promoters in poultry are also expected to limit growth of the market. Growth promoters include hormonal constituents and antibiotics that are widely used in food or meat producing animals, such as poultry animals. There is strong evidence of the negative impact of poultry antibiotics on humans such as induction of antimicrobial-resistant bacteria and disruption of normal human intestinal flora.

Global Poultry Pharmaceuticals Market: Opportunities

R&D in poultry nutrition is expected to offer lucrative growth opportunities for players in the market. For instance, in May 2020, researchers from Veterinary Research Institute, Czech Republic, reported that the TGFβ3 gene could be used as a candidate gene marker for chicken growth traits.

Moreover, increasing demand for poultry over pork as protein is also expected to aid in growth of the market. For instance, in the Philippines, the production of dressed chicken increased 40% during 2009-2018, as per the Philippine Statistics Authority.

The global poultry pharmaceuticals market was valued at US$ 5,337.8 Mn in 2019 and is forecast to reach a value of US$ 10,095.6 Mn by 2027 at a CAGR of 8.2% between 2020 and 2027.

Figure 2. Global Poultry Pharmaceuticals Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Poultry Pharmaceuticals  | Coherent Market Insights

Market Trends/Key Takeaways

The willingness to invest in vaccination is high among backyard poultry in emerging economies. According to the study, ‘Drivers of vaccination preferences to protect a low-value livestock resource: Willingness to pay for Newcastle disease vaccines by smallholder households’, published in the Journal Vaccine in January 2019, the willingness to pay estimate was US$ 2.64 to vaccinate ten chickens against Newcastle disease virus given the vaccine was protective for a period of three month, in Tanzania.

The emergence of COVID-19 has slowed down the demand for poultry products and increased the preference for plant-based meat products in several countries. However, no direct link of poultry products to the spread of virus suggests that the impact on the sales may not be significant.

Global Poultry Pharmaceuticals Market: Competitive Landscape

Major players operating in the global poultry pharmaceuticals market include, Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.

Global Poultry Pharmaceuticals Market: Key Developments

Major players in the market are focused on adopting partnership strategies to enhance their market share. For instance, in February 2020, Avivagen Inc., a developer of products for livestock, companion animal and human applications, partnered with INPHILCO, Inc. for the distribution of OxC-betaTM Livestock in in Philippines.

Major players in the market are also focused on launching new products to expand their product portfolio. For instance, in January 2020, Boehringer Ingelheim's U.S. Animal Health Business launched a vaccine, VAXXITEK HVT+IBD+ND that offers protection against Marek's Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.

Poultry products such as meat, chicken, eggs, and others are widely consumed globally. Demand for these products is on the rise, moreover, increasing demand for animal-based protein is a major factor, which is expected to drive growth of the poultry pharmaceuticals market over the forecast period. For instance, according to Poultry Hub, an initiative of Poultry Hub Australia, worldwide poultry production was around 111,000 thousand metric tons in 2015 and is expected to reach 131,255 thousand metric tons by 2025, exhibiting a CAGR of 24% over the forecast period (2019 to 2027). Several poultry diseases are responsible for loss of poultry products which can be prevented by use of pharmaceutical products.  

Restraints of the Global Poultry Pharmaceuticals Market

Major factors hampering the growth of the poultry pharmaceuticals market during the forecast period constitutes of low product exclusivity, generic competition, and stringent regulations. Product exclusivity period is only three to five years in the animal health care industry.

Key features of the study:

  • This report provides in-depth analysis of the global poultry pharmaceuticals market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global poultry pharmaceuticals market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global poultry pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Poultry Pharmaceuticals Market, By Product Type:
    • Drugs
      • VETRIMOXIN
      • Other Drug Products
    • Vaccines
      • INNOVAX
      • NOBILIS
      • Poulvac
      • Other Vaccine Products
    • Feed Additives
      • VIGOSINE
      • Amnovit
      • Other Feed Additives
  • Global Poultry Pharmaceuticals Market, By Animal Type:
    • Chicken
    • Turkey
    • Duck
    • Goose
    • Others
  • Global Poultry Pharmaceuticals Market, By Geography:
    • North America
      • By Product Type
        • Drugs
          • VETRIMOXIN
          • Other Drug Products
        • Vaccines
          • INNOVAX
          • NOBILIS
          • Poulvac
          • Other Vaccine Products
        • Feed Additives
          • VIGOSINE
          • Amnovit
          • Other Feed Additives
      • By Animal Type:
        • Chicken
        • Turkey
        • Duck
        • Goose
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type
        • Drugs
          • VETRIMOXIN
          • Other Drug Products
        • Vaccines
          • INNOVAX
          • NOBILIS
          • Poulvac
          • Other Vaccine Products
        • Feed Additives
          • VIGOSINE
          • Amnovit
          • Other Feed Additives
      • By Animal Type:
        • Chicken
        • Turkey
        • Duck
        • Goose
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Drugs
          • VETRIMOXIN
          • Other Drug Products
        • Vaccines
          • INNOVAX
          • NOBILIS
          • Poulvac
          • Other Vaccine Products
        • Feed Additives
          • VIGOSINE
          • Amnovit
          • Other Feed Additives
      • By Animal Type:
        • Chicken
        • Turkey
        • Duck
        • Goose
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type
        • Drugs
          • VETRIMOXIN
          • Other Drug Products
        • Vaccines
          • INNOVAX
          • NOBILIS
          • Poulvac
          • Other Vaccine Products
        • Feed Additives
          • VIGOSINE
          • Amnovit
          • Other Feed Additives
      • By Animal Type:
        • Chicken
        • Turkey
        • Duck
        • Goose
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Product Type
        • Drugs
          • VETRIMOXIN
          • Other Drug Products
        • Vaccines
          • INNOVAX
          • NOBILIS
          • Poulvac
          • Other Vaccine Products
        • Feed Additives
          • VIGOSINE
          • Amnovit
          • Other Feed Additives
      • By Animal Type:
        • Chicken
        • Turkey
        • Duck
        • Goose
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Drugs
          • VETRIMOXIN
          • Other Drug Products
        • Vaccines
          • INNOVAX
          • NOBILIS
          • Poulvac
          • Other Vaccine Products
        • Feed Additives
          • VIGOSINE
          • Amnovit
          • Other Feed Additives
      • By Animal Type:
        • Chicken
        • Turkey
        • Duck
        • Goose
        • Others
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Bayer AG*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Bimeda
    • Ceva Sante Animale
    • Elanco Animal Health (Eli Lilly and Company)
    • Merck Animal Health
    • Merial Animal Health (Sanofi)
    • Virbac
    • Boehringer Ingelheim
    • Zoetis, Inc.
    • Pacific GeneTech
    • Avivagen Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Animal Type
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
  4. Global Poultry Pharmaceuticals Market, By Product Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • VETRIMOXIN
        • Other Drug Products
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • INNOVAX
        • NOBILIS
        • Poulvac
        • Other Vaccine Products
    • Feed Additives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • VIGOSINE
        • Amnovit
        • Other Feed Additives
  5. Global Poultry Pharmaceuticals Market, By Animal Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Chicken
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Turkey
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Duck
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Goose
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  6. Global Poultry Pharmaceuticals Market, By Regions, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bimeda
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Ceva Sante Animale
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Elanco Animal Health (Eli Lilly and Company)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck Animal Health
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merial Animal Health (Sanofi)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Virbac
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Zoetis, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pacific GeneTech
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Avivagen Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 33 market data tables and 27 figures on “Poultry Pharmaceuticals Market – Global forecast to 2027.

Frequently Asked Questions

The global poultry pharmaceuticals market was valued at US$ 5,337.8 Mn in 2019 and is forecast to reach a value of US$ 10,095.6 Mn by 2027 at a CAGR of 8.2% between 2020 and 2027.
Major factor driving the growth of global poultry pharmaceuticals market during the forecast period increasing prevalence of animal diseases, and increasing demand for safe poultry products.
Major factors hampering the growth of the poultry pharmaceuticals market during the forecast period constitutes of low product exclusivity, generic competition, and stringent regulations.
Vaccines held dominant position in the global poultry pharmaceuticals market in 2019.
North America poultry pharmaceuticals market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner